A bumper crop of FDA approvals in 2015 means an equal number of launches to keep an eye on in 2016. Last year, FiercePharmaMarketing brought you a list of 8 markets to watch–including some bracing for the next-gen entrants that arrived in 2015. One year later, those newcomers are shaking things up as expected.

Read More